Clinical Trials › NCT05378100
Active, Not RecruitingPhase 2
Ketamine for Multiple Sclerosis Fatigue
Sponsored by Johns Hopkins University
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 110
Target enrollment
1
U.S. states
Jan 2023
Start date
Oct 2026
Expected completion
Interventions / Treatments
KetamineMidazolam
Conditions studied
Multiple Sclerosis Fatigue
Where this trial is running (1 site)
Maryland1 site
Baltimore
Participating MS centers on MS Buddy (1)
Johns Hopkins Multiple Sclerosis Center
Baltimore, MD
Baltimore, MD
MS centers in Maryland
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Maryland centersMore Phase 2 trials
Browse all Phase 2 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
